How Will the Market React to Biomerica Inc (BMRA) Stock Getting a Bullish Rating

Biomerica Inc (BMRA) stock has gained 22.08% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Biomerica Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on BMRA!

See Full BMRA Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With BMRA Stock Today?

Biomerica Inc (BMRA) stock is higher by 14.72% while the S&P 500 has fallen -1.41% as of 2:01 PM on Wednesday, Oct 25. BMRA has risen $0.12 from the previous closing price of $0.82 on volume of 294,148 shares. Over the past year the S&P 500 has gained 10.28% while BMRA has fallen -68.46%. BMRA lost -$0.42 per share in the over the last 12 months.

More About Biomerica Inc

Biomerica Inc is engaged in the development, manufacturing, and marketing medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. Majority of the company's revenue is earned from the Europe market. Click Here to get the full Stock Report for Biomerica Inc stock.